Keyphrases
Adverse Outcomes
100%
BACH2
100%
Chronic Lymphocytic Leukemia
100%
B Cells
80%
Lymphoma
50%
Overall Survival
30%
Leukemia Patients
30%
Protein-protein Interaction Network
20%
Chronic Lymphocytic Leukemia Cells
20%
Mec1
20%
Patient Outcomes
10%
Clinical Significance
10%
Cellular Processes
10%
Clinical Outcomes
10%
Nucleic Acid Metabolism
10%
Protein Expression
10%
Direct Interaction
10%
Prognostic Score
10%
Prognostic Biomarker
10%
Ubiquitination
10%
Low Expression
10%
High-level Expression
10%
Heterogeneous Disease
10%
Leukemia-lymphoma
10%
17p Deletion
10%
Prognostic Role
10%
Basic Leucine Zipper Transcription Factor
10%
Protein Degradation
10%
11q Deletion
10%
Protein Homeostasis
10%
Protein Network
10%
Index Model
10%
Risk Score
10%
RNA Expression
10%
Score Value
10%
13q Deletion
10%
Immunoglobulin Heavy Chain
10%
Receptor Function
10%
Cell Cycle Regulators
10%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
RNA
100%
Protein Interaction
66%
Nucleic Acid Metabolism
33%
Protein Expression
33%
Protein Catabolism
33%
B Cell
33%
Intravenous Immunoglobulin
33%
Ubiquitination
33%
Heavy Chain
33%
Transcription Factor II
33%
Basic Leucine Zipper Transcription Factor
33%
Protein Homeostasis
33%
Medicine and Dentistry
Adverse Outcome
100%
B-Cell Chronic Lymphocytic Leukemia
100%
Chronic Lymphocytic Leukemia
41%
Overall Survival
25%
Leukemia Cell
16%
Interaction Network
16%
Protein Interaction
16%
Disease
8%
Receptor
8%
Biological Marker
8%
Clinical Significance
8%
Ubiquitination
8%
Protein Expression
8%
B Cell
8%
Protein Degradation
8%
Basic Leucine Zipper Transcription Factor
8%
Immunoglobulin Heavy Chain
8%
Transcription Factor II
8%
Protein Homeostasis
8%
Nucleic Acid Metabolism
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
100%
Chronic Lymphatic Leukemia
100%
Overall Survival
25%
Disease
8%
Biological Marker
8%
Receptor
8%
Cellular Processes
8%
Nucleic Acid
8%
Transcription Factor II
8%
Basic Leucine Zipper Transcription Factor
8%
Immunoglobulin Heavy Chain
8%